Objective Indicia Of Nonobviousness Do Not Necessarily Overcome A Strong Showing Of Obviousness
Client Alert | 2 min read | 10.15.08
In Asyst Technologies, Inc. v. Emtrak, Inc. (No. 2007-1554; October 10, 2008), the Federal Circuit affirms a district court's grant of judgment as a matter of law that United States Patent No. 5,097,421 ("'421 patent") is invalid due to obviousness.
The '421 patent provides a system for tracking articles in a manufacturing facility using transportable processing units to carry the articles of manufacture. The transportable units are capable of storing data regarding the status of the articles it contains. The '421 patent uses a multiplexer to communicate between a particular processing unit and the central control unit to ensure that fabrication steps are followed in the correct order. The Hesser patent teaches the same system except that it employs a bus which routes communication from a central control unit to every connected device. The only material difference between the '421 patent and the Hesser patent is the substitution of the multiplexer for the bus as a method of non-contact communication.
The district court granted defendant Jenoptik's motion for judgment as a matter of law that the '421 patent was invalid as obvious in view of the Hesser patent. The district court concluded that the patent validity verdict was fundamentally undermined by the jury's erroneous conclusion that the Hesser patent was not relevant prior art. The Federal Circuit agrees. Asyst contended that since Hesser teaches indiscriminate information transmission to all processing units, the '421 patent produces the unexpected result of saving battery life by communicating with only one unit at a time. However, Jenoptik produced credible evidence that multiplexers and their advantages and disadvantages were well known and well understood by persons of skill in the art at the time of the '421 patent application. In view of the Supreme Court's decision in KSR Int'l Co. v. Teleflex, Inc., 127 S. Ct. 1727 (2007), the Court holds that replacing the bus with the multiplexer is "little more than the simple substitution of one known element for another." Asyst raised objective indicia of nonobviousness including commercial success, long-felt need, and industry praise as sufficient support for the jury's patent validity verdict. However, Asyst failed to attribute the objective indicia to the substitution of the multiplexer for the bus. Thus, the Federal Circuit concludes that this failure undermined the probative force of the secondary evidence. Consequently, it was obvious to a person of ordinary skill in the art to replace the bus in Hesser with a multiplexer, and the objective indicia of nonobviousness were insufficient to overcome the strong showing of obviousness in this case.
Contacts
Insights
Client Alert | 2 min read | 05.27.25
Federal Circuit Resolves Circuit Split on Scope of IPR Estoppel
As part of the 2012 America Invents Act, statutory estoppel was included to balance the interests of patent owners and patent challengers following an inter partes review (“IPR”). Estoppel prevents an IPR petitioner from later asserting in court that a claim “is invalid on any ground that the petitioner raised or reasonably could have raised” during the IPR. 35 U.S.C. § 315(e)(2). As applied, estoppel prevents petitioners from later relying in district court or in ITC proceedings on most patents or printed publications – the limited bases upon which petitioner can rely in an IPR. But a question remained, and contradictory district court decisions arose, as to whether petitioners would be estopped from relying on a prior art commercial product (known as “device art,” which could not itself have been raised in the IPR) even if a printed publication describing the product (i.e. a patent or technical manual) was available and presumably could have been raised.
Client Alert | 6 min read | 05.27.25
U.S. Departments of State and Treasury Issue Immediate Sanctions Relief for Syria
Client Alert | 3 min read | 05.23.25
Executive Order Seeks Most-Favored-Nation Drug Pricing and HHS Announces Price Targets
Client Alert | 4 min read | 05.22.25
Opportunities for Procurement on the Horizon as UK Concludes Free Trade Agreement With India